Daniel A. Camardo
CIK: 0001820365
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CUE
Cue Biopharma, Inc.
Director
Discretionary Trading P&L
Holdings
About Camardo Daniel A.
Camardo Daniel A. (SEC CIK 0001820365) files insider reports with the SEC as Director of Cue Biopharma, Inc. (CUE).
Signal8 holds 3 ownership filings by Camardo Daniel A. (1 Form 3, 2 Form 4), filed between Jun 8, 2026 and Jul 10, 2026. Those filings report 2 transactions, from May 30, 2026 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Camardo Daniel A.'s filings is in BOSTON, MA.
Recent filings by Camardo Daniel A.
Other insiders filing for Cue Biopharma, Inc. (CUE)
- Ray Sumita, Chief Legal Compliance Officer
- Meluzio Michael Vincent, VP, Prin. Accounting Officer
- Lin Shao-Lee, Chief Executive Officer
- Sarraf Pasha, Director
- Garzone Pamela, Director
- Ahlers James M, Chief Financial Officer